FIELD: medicine.
SUBSTANCE: method involves introducing F2a prostaglandin to 2-3 months old SHR-line rats in dropping infusion mode at a dose of 1.25-1.5 mcg in 5 ml of 5% glucose solution during 40-60 min 3 times a day with 2 days long pauses.
EFFECT: high accuracy of modeling.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ARTERIAL HYPERTENSION | 2010 |
|
RU2418592C1 |
| METHOD FOR SIMULATING RENOPARENCHYMATOUS ARTERIAL HYPERTENSION IN RATS | 2012 |
|
RU2507593C1 |
| INDOL DERIVATIVE DISPLAYING ANTIHYPERTENSIVE ACTION AND ITS PRODUCTION METHOD | 2010 |
|
RU2451670C2 |
| METHOD FOR TREATMENT OF ARTERIAL HYPERTENSION IN ALDOSTERONISM | 0 |
|
SU1690699A1 |
| METHOD OF TREATMENT OF HYPERTENSION | 0 |
|
SU1393429A1 |
| METHOD FOR DETERMINING INDICATIONS FOR PORTALIZATION OF SUPRARENAL GLAND BLOOD OUTFLOW IN PATIENTS SUFFERING FROM HYPERTENSION AND HYPERALDOSTERONISM | 0 |
|
SU1827625A1 |
| METHOD OF DETERMINING OPTIMUM LEVEL OF DROPPING ARTERIAL PRESSURE OF PATIENTS HAVING HIGHLY STABLE AND MALIGNANT HYPERTENSION | 0 |
|
SU1324639A1 |
| METHOD OF ASSESSING AGE-RELATED CHANGES OF HUMAN CARDIOVASCULAR SYSTEM | 2012 |
|
RU2485886C1 |
| METHOD OF EARLY DIAGNOSTICS OF VARIOUS FORMS OF ESSENTIAL ARTERIAL HYPERTENSION IN CHILDREN AND ADOLESCENTS | 2016 |
|
RU2648453C1 |
| METHOD FOR TREATING ARTERIAL HYPERTENSION IN PATIENTS WITH CEREBROVASCULAR DISEASES | 2003 |
|
RU2238075C1 |
